Outcomes of Phacoemulsification and Trabeculectomy for Uncontrolled Glaucoma and Cataract: A Comparison of Staged and Combined Techniques in a Single-Center Observational Study - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Outcomes of Phacoemulsification and Trabeculectomy for Uncontrolled Glaucoma and Cataract: A Comparison of Staged and Combined Techniques in a Single-Center Observational Study

  • By

  • Matteo Sacchi

  • Gianluca Monsellato

  • Davide Rastelli

  • Shadan Ranaei

  • Davide Tomaselli

  • Gaia Li Calzi

  • Edoardo Villani

  • Stefano Dore

  • Antonio Pinna

  • Paolo Nucci

  • February 9, 2026

Share

  • 1

    Cataract and glaucoma are leading causes of blindness, necessitating effective surgical interventions for patients with both conditions.

  • 2

    Phacoemulsification and trabeculectomy can be performed as staged or combined approaches, each with distinct benefits and risks.

  • 3

    A combined approach may reduce treatment time and postoperative IOP spikes but is technically more demanding and associated with higher complication rates.

  • 4

    Previous studies show conflicting results regarding the efficacy of staged versus combined approaches, highlighting the need for longer follow-up.

  • 5

    This study aims to evaluate long-term outcomes of both surgical techniques in patients with uncontrolled glaucoma and significant cataract.

Original Source(s)

Outcomes of Phacoemulsification and Trabeculectomy for Uncontrolled Glaucoma and Cataract: A Comparison of Staged and Combined Techniques in a Single-Center Observational Study

  • by Matteo Sacchi, Gianluca Monsellato, Davide Rastelli, Shadan Ranaei, Davide Tomaselli, Gaia Li Calzi, Edoardo Villani, Stefano Dore, Antonio Pinna, Paolo Nucci

  • February 9, 2026

Related Content

Impact of the Personalized Glaucoma Coaching Program on Adherence to Medication: Support, Educate, Empower Approach

Error in Methods

  • September 1, 2026

Trends and Regional Differences in the Prescription of Prostaglandin Analogs for Glaucoma in England from 2019 to 2024